Hypertension
Showing NaN - NaN of 152
Hypertension, Hypercholesterolemia Trial in Worldwide (Amlodipine besylate/atorvastatin calcium single pill combination)
Completed
- Hypertension
- Hypercholesterolemia
- Amlodipine besylate/atorvastatin calcium single pill combination
-
Desamparados, San Jose, Costa Rica
- +125 more
Jan 26, 2021
Hypertension, Hyperlipidemia Trial in Worldwide (Amlodipine/atorvastatin single pill)
Completed
- Hypertension
- Hyperlipidemia
- Amlodipine/atorvastatin single pill
-
Buenos Aires, Argentina
- +117 more
Jan 26, 2021
Hypercholesterolemia, Hypertension Trial in Seoul (Ezetimibe/Rosuvastatin, Telmisartan)
Completed
- Hypercholesterolemia
- Hypertension
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 13, 2021
Hypertension Trial in Seoul (Rosuvastatin, Life style modification)
Completed
- Hypertension
- Rosuvastatin
- Life style modification
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 11, 2021
Hypertension, Dyslipidemias Trial in Seoul (HCP1701, Losartan, Amlodipine)
Completed
- Hypertension
- Dyslipidemias
- HCP1701
- +3 more
-
Seoul, Seoul-si, Korea, Republic ofSeoul National University Hospital
Nov 26, 2020
Hypertension Trial in Seoul, Wonju (Manidipine 20mg, Amlodipine 10mg)
Terminated
- Hypertension
- Manidipine 20mg
- Amlodipine 10mg
-
Seoul, Korea, Republic of
- +2 more
Sep 2, 2020
Hypertension Trial in Seoul (Candesartan 16mg, Amlodipine 5mg, Amlodipine 10mg)
Completed
- Hypertension
- Candesartan 16mg
- +2 more
-
Seoul, Korea, Republic ofSeverance Hospital
Aug 23, 2020
Hypertension Trial in Korea, Republic of (Cantabell Tab, Candemore Plus Tab)
Completed
- Hypertension
- Cantabell Tab
- Candemore Plus Tab
-
Suwon, Gyeonggi-do, Korea, Republic of
- +13 more
Aug 18, 2020
Hypertension, Dyslipidemias Trial in Seoul (CKD-348 F1, CKD-348 F2, CKD-828, D097, D337)
Completed
- Hypertension
- Dyslipidemias
- CKD-348 F1
- +2 more
-
Seoul, Gwanak-gu, Korea, Republic ofH Plus Yangji Hospital
Jun 3, 2020
Hypertension, Diabetes Trial in Seoul (Treatment A (Fimasartan, Linagliptin), Treatment B (Fimasartan/Linagliptin))
Completed
- Hypertension
- Diabetes
- Treatment A (Fimasartan, Linagliptin)
- Treatment B (Fimasartan/Linagliptin)
-
Seoul, Dahak-ro, Korea, Republic ofSeoul National University Hospital
Feb 3, 2020
Hypertension Trial in Daegu, Seoul (Telemonitoring, Telemonitoring & Telemedicine, control group)
Completed
- Hypertension
- Telemonitoring
- +2 more
-
Daegu, Korea, Republic of
- +2 more
Jan 29, 2020
Hypertension Trial in Korea, Republic of (Telminuvo®Tab. 40/2.5mg, Telmitrend®Tab. 80mg)
Completed
- Hypertension
- Telminuvo®Tab. 40/2.5mg
- Telmitrend®Tab. 80mg
-
Gyeonggi-do, Ansan-si, Korea, Republic of
- +10 more
Jan 29, 2020
Fimasartan Blood Pressure Lowering After Acute Stroke
Completed
- Hypertension
- +2 more
-
Ansan, Korea, Republic of
- +26 more
Nov 1, 2019
Hypertension, Dyslipidemias Trial in Seoul (Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination)), Two separated
Completed
- Hypertension
- Dyslipidemias
- Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination))
- Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin)
-
Seoul, Korea, Republic ofDivision of Cardiology, Severance Cardiovascular Hospital, Yonse
Aug 19, 2019
Hyperlipidemias, Hypertension Trial in Seoul (AD-2071 10/20mg, AD-2072 80/5mg, AD-2071 10/20mg + AD2072 80/5mg)
Completed
- Hyperlipidemias
- Hypertension
- AD-2071 10/20mg
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 2, 2019
Chronic Kidney Diseases, Renal Insufficiency, Chronic, Albuminuria Trial in Seoul (Ambulatory blood pressure monitoring (ABPM))
Unknown status
- Chronic Kidney Diseases
- +3 more
- Ambulatory blood pressure monitoring (ABPM)
-
Seoul, Korea, Republic of
- +3 more
Jun 3, 2019
Hypertension Trial in Seoul (telmisartan/amlodipine 40/5mg, YH22162 40/5/12.5 mg, telmisartan/amlodipine 80/5mg)
Completed
- Hypertension
- telmisartan/amlodipine 40/5mg
- +7 more
-
Seoul, Korea, Republic ofYuhan
Mar 7, 2019
Hypertension, Dyslipidemias Trial in Seoul (CKD-333, formula I, CKD-333, formula II, CKD-330, D090)
Unknown status
- Hypertension
- Dyslipidemias
- CKD-333, formula I
- +2 more
-
Seoul, Korea, Republic ofSeoul Saint Mary's Hospital
Feb 21, 2019
Hypertension, Hyperlipidemia Trial in Seoul (Temisartan+Amlodipine+Rosuvastatin (Combination drug), Temisartan+Amlodipine,
Completed
- Hypertension
- Hyperlipidemia
- Temisartan+Amlodipine+Rosuvastatin (Combination drug)
- +2 more
-
Seoul, Jongno, Korea, Republic ofSeoul Natuional University Hospital
Jan 14, 2019
Dyslipidemias, Hypertension Trial in Seoul (Sequence 1, Sequence 2, Sequence 3)
Unknown status
- Dyslipidemias
- Hypertension
- Sequence 1
- +5 more
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan
Oct 30, 2018
Hypertension, Dyslipidemias Trial in Seoul (CKD-333 formulation I, CKD-333 formulation II, CKD-330+D086)
Completed
- Hypertension
- Dyslipidemias
- CKD-333 formulation I
- +2 more
-
Seoul, Korea, Republic ofSeoul Saint Mary's Hospital
Oct 29, 2018
Hypertension, Dyslipidemias, Diabetes Trial in Seoul (ICT programs, A book about chronic disease)
Completed
- Hypertension
- +2 more
- ICT programs
- A book about chronic disease
-
Seoul, Korea, Republic ofSeoul National University
Oct 22, 2018
Hypertension Trial in Seoul (Group I, Group II)
Unknown status
- Hypertension
- Group I
- Group II
-
Seoul, Korea, Republic ofYonsei University Severance Cardiovascular Hospital
Oct 15, 2018